$982.29
14.31[1.48%]
At close: May 17
$982.29
0[0.00%]
After Hours: 4:00PM EDT
Regeneron Pharmaceuticals: Insider buying and selling updated today.
May 17, 2024 | Leonard S Schleifer | BD. CO-CHAIR, PRESIDENT & CEO | -22.83K | $979.23 | -$22.36M | SELL | -4.12% | 531.862K | May 17 | View |
May 17, 2024 | George Yancopoulos | BD. CO-CHAIR, PRESIDENT & CSO | -50K | $972.73 | -$48.64M | SELL | -5.85% | 804.531K | May 16 | View |
May 17, 2024 | George Yancopoulos | BD. CO-CHAIR, PRESIDENT & CSO | -50K | $975.87 | -$48.79M | SELL | -5.53% | 854.531K | May 15 | View |
May 15, 2024 | Leonard S Schleifer | BD. CO-CHAIR, PRESIDENT & CEO | 22.83K | $688.50 | -$95.08M | SELL-OPTIONS | 5.20% | 462.244K | May 13 - May 15 | View |
May 03, 2024 | Marion McCourt | EVP COMMERCIAL | -250 | $889.41 | -$222.35K | SELL | -1.87% | 13.105K | May 01 | View |
May 03, 2024 | Arthur F Ryan | DIRECTOR | -100 | $899.61 | -$89.96K | SELL | -0.55% | 18.082K | May 01 | View |
May 01, 2024 | George Yancopoulos | BD. CO-CHAIR, PRESIDENT & CSO | -16.848K | $900.00 | -$15.16M | SELL | -4.74% | 338.41K | Jan 02 | View |
Apr 03, 2024 | Arthur F Ryan | DIRECTOR | -100 | $962.53 | -$96.25K | SELL | -0.55% | 18.182K | Apr 01 | View |
Apr 03, 2024 | Marion McCourt | EVP COMMERCIAL | -250 | $964.73 | -$241.18K | SELL | -1.84% | 13.339K | Apr 01 | View |
Mar 15, 2024 | Andrew Murphy | EVP RESEARCH | 0 | $683.52 | -$11.35M | SELL-OPTIONS | 0.00% | 52.616K | Mar 13 - Mar 14 | View |
Mar 05, 2024 | Arthur F Ryan | DIRECTOR | -100 | $982.05 | -$98.21K | SELL | -0.54% | 18.282K | Mar 01 | View |
Mar 05, 2024 | Marion McCourt | EVP COMMERCIAL | -358 | $967.50 | -$346.37K | SELL | -2.57% | 13.589K | Mar 01 | View |
Feb 28, 2024 | Joseph LaRosa | EVP GENERAL COUNSEL AND SECRET | -1K | $990.00 | -$990.00K | SELL | -2.64% | 36.898K | Feb 26 | View |
Feb 28, 2024 | George L Sing | DIRECTOR | 0 | $702.91 | -$579.17K | SELL-OPTIONS | 0.00% | 27.349K | Feb 26 | View |
Feb 26, 2024 | Bonnie L Bassler | DIRECTOR | 0 | $685.59 | -$501.58K | SELL-OPTIONS | 0.00% | 1.382K | Feb 26 | View |
Feb 26, 2024 | Joseph LaRosa | EVP GENERAL COUNSEL AND SECRET | -1K | $967.65 | -$967.65K | SELL | -2.57% | 37.898K | Feb 22 | View |
Feb 26, 2024 | George L Sing | DIRECTOR | 0 | $690.59 | -$1.94M | SELL-OPTIONS | 0.00% | 27.349K | Feb 22 - Feb 23 | View |
Feb 16, 2024 | Daniel P. Van Plew | EVP & GENERAL MGR, INDUSTRIAL | -10.434K | $942.28 | -$9.83M | SELL | -32.71% | 21.462K | Feb 14 | View |
Feb 12, 2024 | George L Sing | DIRECTOR | 0 | $681.66 | -$536.67K | SELL-OPTIONS | 0.00% | 27.349K | Feb 08 - Feb 09 | View |
Feb 12, 2024 | Christopher R Fenimore | SVP FINANCE & CFO | -4.919K | $953.31 | -$4.69M | SELL | -24.91% | 14.832K | Feb 09 | View |
Feb 09, 2024 | Joseph LaRosa | EVP GENERAL COUNSEL AND SECRET | -1K | $950.00 | -$950.00K | SELL | -2.51% | 38.898K | Feb 07 | View |
Feb 08, 2024 | Neil Stahl | EVP RESEARCH AND DEVELOPMENT | -8.037K | $950.35 | -$7.64M | SELL | -12.43% | 56.624K | Feb 07 | View |
Feb 06, 2024 | Marion McCourt | EVP COMMERCIAL | -1K | $934.71 | -$934.71K | SELL | -6.69% | 13.947K | Feb 05 | View |
Feb 05, 2024 | Arthur F Ryan | DIRECTOR | -100 | $954.22 | -$95.42K | SELL | -0.54% | 18.382K | Feb 01 | View |
Feb 02, 2024 | Marion McCourt | EVP COMMERCIAL | -273 | $945.61 | -$258.15K | SELL | -1.79% | 14.947K | Feb 01 | View |
Jan 31, 2024 | Bonnie L Bassler | DIRECTOR | 0 | $669.97 | -$478.05K | SELL-OPTIONS | 0.00% | 1.382K | Jan 30 | View |
Jan 25, 2024 | Joseph L Goldstein | DIRECTOR | 0 | $787.80 | -$878.15K | SELL-OPTIONS | 0.00% | 6.382K | Jan 23 | View |
Jan 04, 2024 | George Yancopoulos | BD. CO-CHAIR, PRESIDENT & CSO | -16.848K | $900.00 | -$15.16M | SELL | -4.74% | 338.41K | Jan 02 | View |
Jan 04, 2024 | Marion McCourt | EVP COMMERCIAL | -274 | $873.91 | -$239.45K | SELL | -1.77% | 15.22K | Jan 02 | View |
Jan 04, 2024 | Bonnie L Bassler | DIRECTOR | 135 | $647.48 | -$440.30K | SELL-OPTIONS | 10.83% | 1.382K | Jan 02 - Jan 03 | View |
Browse insider trades on all stocks.